Skip to content Skip to footer

Big Pharma Is Killing Us

Companies that make our medicine don’t do it for public health – they do it for profit.

As drug costs continue to climb, we're creating a two-tiered society: those who can afford to pay to stay alive, and those who can't. (Photo: Pills and Money via Shutterstock)

Drug company profits are literally killing people – and now even doctors are speaking out.

Dr. Leonard Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center, rebuked the pharmaceutical industry for the sharp rise in cancer drug prices over the last decade.

The median monthly price for new cancer drugs nearly doubled between 2000 and 2014 – from a monthly cost of $4,716 between 2000 and 2004 to a monthly cost of about $9,900 between 2010 and 2014.

Dr. Saltz explained part of the problem: “Cancer-drug prices are not related to the value of the drug. Prices are based on what has come before and what the seller believes the market will bear.”

See more news and opinion from Thom Hartmann at Truthout here.

And that’s a neat feature of our current patent system: Drug companies don’t have to worry about what people can afford to pay for a product. Because monopolies set their own prices. And that’s what a patent is: a state-backed monopoly on a product.

Thomas Jefferson knew that monopolies would be a threat to the people and the people’s government.

Jefferson wrote to James Madison on December 20, 1787, expressing concern that the draft of the Constitution did not include a Bill of Rights “providing clearly […] for freedom of religion, freedom of press, protection against standing armies, restriction of monopolies, the eternal and unremitting force of habeas corpus laws, and trials by jury…”

Jefferson wanted safeguards from monopolies included in our Bill of Rights, but a patent gives a company the state-sponsored monopoly on a product for the term of the patent.

And patents aren’t inherently bad. It would be hugely discouraging to inventors and writers if any old troll can steal a novel idea and peddle it without crediting the inventor.

That’s why Article 1, Section 8 of the Constitution gives Congress the power “to promote the progress of science and useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries.”

And that’s what the writers of our Constitution wanted our patents to do: encourage innovations for the public good by allowing innovators exclusive rights to their inventions or writings for a limited time.

But as corporate power has taken hold of every aspect of our government, copyright and patent law in the US has changed dramatically.

The 1790 Patent Act allowed patents to last for seven years with a one-time renewal offered in certain cases.

Now patents last for 20 years after filing, and drug companies even enjoy special extensions to make up for delays in FDA approval.

And that means that drug companies don’t have to worry about competitive pricing or creating demand because the consumer can only choose between treatment or misery and death.

So when a company develops a drug that treats a life-threatening illness, they can simply set their price: $1,000 per pill for Hepatitis C treatment; $10,000 for a month of cancer treatment; $300,000 for the year of treatment.

Can’t pay? Don’t want to pay?

Maybe you’d prefer to die. It’s all the same to the companies.

Because the companies that make our medicine don’t do it for public health – they do it for profit.

Corporations like Walt Disney and Bristol Myer Squibb have lobbied to shape patent and copyright law to fill their corporate coffers instead of “promoting the progress of science and the useful arts.”

As drug costs continue to climb, we’re creating a two-tiered society: those who can afford to pay to stay alive, and those who can’t.

Public health is an issue of the commons, and it’s time that we reform patent law to discourage monopolistic price-gouging on drugs that treat life-threatening illnesses.

And that requires getting corporate money out of our political system so that companies can’t buy politicians who support granting patents indefinitely.

We’re not backing down in the face of Trump’s threats.

As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.

Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.

As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.

At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.

Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.

You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.